Form 4 for MRNA Moderna
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001682852-26-000038 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-02-27 | MRNA | Mock James M | CFO | F - Tax | $51.71 | -5,323 | 50.9K | -9% | -$275.3K |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Mock James M | CFO | M - OptEx | — | +11.0K | 46.2K | +31% | — |
| DM | 2026-03-03 | 2026-02-27 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -11.0K | 1,315 | -89% | $0 |
| DM | 2026-03-03 | 2026-03-01 | MRNA | Mock James M | CFO | A - Grant | $0.00 | +87.2K | 49.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | F | D | 375 | $51.71 | 45,792 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-27 | M | A | 9,901 | — | 55,693 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2026-02-27 | F | D | 160 | $51.71 | 45,393 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-27 | M | A | 329 | — | 45,553 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2026-02-27 | M | A | 774 | — | 46,167 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 6 | Common | Common Stock | 2026-02-27 | F | D | 4,788 | $51.71 | 50,905 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 774 | $0.00 | 6,189 | D | — · — to — | 774 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 8 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 9,901 | $0.00 | 29,705 | D | — · — to — | 9,901 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 9 | Derivative | Restricted Stock Units | 2026-02-27 | M | D | 329 | $0.00 | 1,315 | D | — · — to — | 329 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-03-01 | A | A | 37,639 | $0.00 | 37,639 | D | $53.57 · 2027-03-01 to 2036-03-01 | 37,639 Common Stock | (F6) 25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 11 | Derivative | Restricted Stock Units | 2026-03-01 | A | A | 49,569 | $0.00 | 49,569 | D | — · — to — | 49,569 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F7) 25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |